9 stories mentioning OSCR
Every FINWIRES story that references OSCR, newest first.
Oscar Health (OSCR) has an average rating of hold and mean price target of $22.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Oscar Health (OSCR) shares rose more than 16% in late Thursday trading after Wells Fargo upgraded the health insurer to equalweight from underweight and raised its price target to $20 from $11.Trading volume stood at over 7.9 million shares compared with a daily average of about 7.2 million shares.Price: $23.82, Change: $+3.32, Percent Change: +16.20%
Oscar Health (OSCR) has an average rating of hold and mean price target of $22.18, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Richard Scott Blackley, Chief Financial Officer, on May 14, 2026, sold 100,000 shares in Oscar Health (OSCR) for $2,316,031. Following the Form 4 filing with the SEC, Blackley has control over a total of 1,291,660 Class A common shares of the company, with 1,216,660 shares held directly and 75,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1568651/000152502026000007/xslF345X05/wk-form4_1779135348.xml
Oscar Health (OSCR) has an average rating of hold and mean price target of $18.91, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $20.16, Change: $+0.33, Percent Change: +1.66%
Health care stocks were higher late Wednesday afternoon, with the NYSE Health Care Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.2%.The iShares Biotechnology ETF (IBB) climbed up 2.1%.In corporate news, Oscar Health (OSCR) shares surged past 10% after the company reported higher Q1 results.DaVita (DVA) shares jumped past 22% after Deutsche Bank upgraded the stock to buy from hold and boosted its price target to $220 from $126, a day after the company reported better-than-expected Q1 results.CVS Health (CVS) raised its full-year earnings outlook after reporting better-than-expected Q1 results on improvement in its health-care benefits segment. Its shares gained 8%.Novo Nordisk (NVO) expects generic versions of its Ozempic medication to face approval delays in China until next year, Bloomberg reported, citing the drugmaker. The patent for semaglutide, the main ingredient in Ozempic and Wegovy, expired in China in March, but the firm said it still has regulatory data protection until April 2027 due to a trade agreement between China and Switzerland, Bloomberg reported. Novo shares rose 2.2%.
(Updates with the latest stock movement in the first paragraph and headline.)Oscar Health (OSCR) shares were up past 10% in Wednesday afternoon trading after the company reported higher Q1 results.The company reported Q1 adjusted earnings Wednesday of $2.07 per diluted share, up from $0.92 a year earlier.Analysts polled by FactSet expected $1.11.Revenue for the quarter ended March 31 was $4.65 billion, up from $3.05 billion a year earlier.Analysts surveyed by FactSet expected $4.90 billion.The company reaffirmed its full-year 2026 guidance across all metrics.Price: $19.79, Change: $+1.85, Percent Change: +10.32%
Health care stocks were higher premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF (XLV) gaining by 0.1% and the iShares Biotechnology ETF (IBB) advancing 1%.Novo Nordisk (NVO) stock was up more than 6% premarket after the company posted higher-than-expected Q1 earnings and revenue in addition to raising its 2026 adjusted sales growth guidance.Royal Philips (PHG) shares were up more than 1% pre-bell after the company reported higher-than-expected Q1 adjusted income from continuing operations and revenue.Oscar Health (OSCR) stock was up over 9% premarket after the company reported higher Q1 adjusted earnings and revenue.
Oscar Health (OSCR) has an average rating of hold and mean price target of $16.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)